Epidemiology of hemorrhagic strokes;Épidémiologie des accidents hémorragiques cérébraux

Journal of Neuroradiology

Volumn 30, Issue 5, 2003, Pages 291-297

  Gere, J ^a   Minier, D ^a   Osseby, G V ^a   Couvreur, G ^a   Moreau, T ^a   Ricolfi, F ^a   Giroud, M ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Epidemiology; Hemorrhagic stroke; Spontaneous intracerebral hemorrhage; Subarachnoid hemorrhage

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIVITAMIN K; HEPARIN DERIVATIVE;

ANTICOAGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE COURSE; EPIDEMIOLOGICAL DATA; FRANCE; HUMAN; HYPERTENSION; INCIDENCE; PATHOGENESIS; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE; VASCULAR AMYLOIDOSIS; CEREBROVASCULAR ACCIDENT; REVIEW; SUBARACHNOID SPACE; TIME;

CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; HUMANS; INCIDENCE; SUBARACHNOID SPACE; TIME FACTORS;

EID: 0347601952     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (65)

1. ABDULRAUF SI, MALIK GM, AWAD IA. Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery 1999; 44: 280-287.
2. ARAKAWA S, SAKU Y, IBAYASHI S, NAGAO T, FUJISHIMA M. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998; 29: 1806-1809.
3. AYALA C, CROFT JB, GREENLUND KJ, KEENAN NL, DONEHOO RS, MALARCHER AM et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 2002; 33: 1197-1201.
4. BECKER KJ. Epidemiology and clinical presentation of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 1998; 9: 435-444.
5. BRODERICK JP, BROTT T, TOMSICK T, HUSTER G, MILLER R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 1992; 326: 733-736.
6. BRODERICK JP, BROTT T, TOMSICK T, MILLER R, HUSTER G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993; 78: 188-191.
7. BRODERICK JP, BROTT TG, DULDNER JE, TOMSICK T, HUSTER G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-993.
8. BROTT T, BRODERICK J, KOTHARI R, BARSAN W, TOMSICK T, SAUERBECK L et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1-5.
9. CATTO AJ, KOHLER HP, BANNAN S, STICKLAND M, CARTER A, GRANT PJ. Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke 1998; 29: 813-816.
10. DE BRAEKELEER M, PERUSSE L, CANTIN L, BOUCHARD JM, MATHIEU J. A study of inbreeding and kinship in intracranial aneurysms in the Saguenay Lac-Saint-Jean region (Quebec, Canada). Ann Hum Genet 1996; 60: 99-104.
11. DEL ZOPPO GJ, MORI E. Hematologic causes of intracerebral hemorrhage and their treatment. Neurosurg Clin N Am 1992; 3: 637-658.
12. FESSLER RD, ESSHAKI CM, STANKEWITZ RC, JOHNSON RR, DIAZ FG. The neurovascular complications of cocaine. Surg Neurol 1997; 47: 339-345.
13. GALLERANI M, TRAPPELLA G, MANFREDINI R, PASIN M, NAPOLITANO M, MIGLIORE A. Acute intracerebral haemorrhage: circadian and circannual patterns of onset. Acta Neurol Scand 1994; 89: 280-286.
14. GEBEL JM, SILA CA, SLOAN MA, GRANGER CB, MAHAFFEY KW, WEISENBERGER J et al. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke 1998; 29: 563-569.
15. GIROUD M, CREISSON E, FAYOLLE H, ANDRE N, BECKER F, MARTIN D et al. Risk factors for primary cerebral hemorrhage: a population-based study - the Stroke Registry of Dijon. Neuroepidemiology 1995; 14: 20-26.
16. GIROUD M, GRAS P, CHADAN N, BEURIAT P, MILAN C, ARVEUX P et al. Cerebral haemorrhage in a French prospective population study. J Neurol Neurosurg Psychiatry 1991; 54: 595-598.
17. GIROUD M, GRAS P, FAYOLLE H, ANDRE N, SOICHOT P, DUMAS R. Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 1994; 35: 959-964.
18. GIROUD M, MILAN C, BEURIAT P, GRAS P, ESSAYAGH E, ARVEUX P et al. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol 1991; 20: 892-899.
19. GREENBERG SM. Cerebral amyloid angiopathy and vessel dysfunction. Cerebrovasc Dis 2002; 13: 42-47.
20. GREENBERG SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998; 51: 690-694.
21. GROSS CR, KASE CS, MOHR JP, CUNNINGHAM SC, BAKER WE. Stroke in south Alabama: incidence and diagnostic features - a population based study. Stroke 1984; 15: 249-255.
22. GUNNAR GUDMUNDSSON, ELIAS OLAFSSON, HANNES BLONDAL, LEIFUR THORSTEINSSON, ALFRED ARNASONHEREDITARY. Cerebral amyloid angiopathy. Lancet 1998; 352: S4.
23. HARTMANN A, MAST H, MOHR JP, KOENNECKE HC, OSIPOV A, PILE-SPELLMAN J et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998; 29: 931-934.
24. INAGAWA T, HIRANO A. Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol 1990; 34: 361-365.
25. INAGAWA T, TOKUDA Y, OHBAYASHI N, TAKAYA M, MORITAKE K. Study of aneurysmal subarachnoid hemorrhage in Izumo City, Japan. Stroke 1995; 26: 761-766.
26. ISO H, JACOBS DR JR, WENTWORTH D, NEATON JD, COHEN JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989; 6; 320: 904-910.
27. ITOH Y, YAMADA M, HAYAKAWA M, OTOMO E, MIYATAKE T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993; 116: 135-141.
28. JOHNSTON SC, COLFORD JM JR, GRESS DR. Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis. Neurology 1998; 51: 411-418.
29. JUVELA S, HILLBOM M, NUMMINEN H, KOSKINEN P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke 1993; 24: 639-646.
30. JUVELA S, PORRAS M, HEISKANEN O. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. J Neurosurg 1993; 79: 174-182.
31. KAZUI S, MINEMATSU K, YAMAMOTO H, SAWADA T, YAMAGUCHI T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997; 28: 2370-2375.
32. KERNAN WN, VISCOLI CM, BRASS LM, BRODERICK JP, BROTF T, FELDMANN E et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000; 343: 1826-1832.
33. KNEKT P, REUNANEN A, AHO K, HELIOVAARA M, RISSANEN A, AROMAA A et al. Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol 1991; 44: 933-939.
34. KONDZIOLKA D, LUNSFORD LD, KESTLE JR. The natural history of cerebral cavernous malformations. J Neurosurg 1995; 83: 820-824.
35. KWIATKOWSKI TG, LIBMAN RB, FRANKEL M, TILLEY BC, MORGENSTERN LB, LU M et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999; 340: 1781-1787.
36. LITCH JA, BASNYAT B, ZIMMERMAN M. Subarachnoid hemorrhage at high altitude. West J Med 1997; 167: 180-181.
37. LONGSTRETH WT JR, NELSON LM, KOEPSELL TD, VAN BELLE G. Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke 1992; 23: 1242-1249.
38. MANSON JE, STAMPFER MJ, COLDITZ GA, WILLETT WC, ROSNER B, SPEIZER FE et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991; 266: 521-527.
39. NAFF NJ, WEMMER J, HOENIG-RIGAMONTI K, RIGAMONTI DR. A longitudinal study of patients with venous malformations: documentation of a negligible hemorrhage risk and benign natural history. Neurology 1998; 50: 1709-1714.
40. NIIZUMA H, SUZUKI J, YONEMITSU T, OTSUKI T. Spontaneous intracerebral hemorrhage and liver dysfunction. Stroke 1988; 19: 852-856.
41. O'DONNELL HC, ROSAND J, KNUDSEN KA, FURIE KL, SEGAL AZ, CHIU RI et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 240-245.
42. OSTBYE T, LEVY AR, MAYO NE. Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke 1997; 28: 793-798.
43. PASSERO S, REALE F, CIACCI G, ZEI E. Differing temporal patterns of onset in subgroups of patients with intracerebral hemorrhage. Stroke 2000; 31: 1538-1544.
44. PETITTI DB, SIDNEY S, BERNSTEIN A, WOLF S, QUESENBERRY C, ZIEL HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996; 335: 8-15.
45. PHILLIPS LH 2ND, WHISNANT JP, O'FALLON WM, SUNDT TM JR. The unchanging pattern of subarachnoid hemorrhage in a community. Neurology 1980; 30: 1034-1040.
46. PRETER M, TZOURIO C, AMERI A, BOUSSER MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996; 27: 243-246.
47. QURESHI AI, GILES WH, CROFT JB. Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology 1999; 52: 1617-1621.
48. QURESHI AI, SAFDAR K, PATEL M, JANSSEN RS, FRANKEL MR. Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke 1995; 26: 1995-1998.
49. QURESHI AI, SAFDAR K, WEIL J, BARCH C, BLIWISE DL, COLOHAN AR et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 1995; 26: 1764-1767.
50. RINNE JK, HERNESNIEMI JA. De novo aneurysms: special multiple intracranial aneurysms. Neurosurgery 1993; 33: 981-985.
51. RONKAINEN A, MIETTINEN H, KARKOLA K, PAPINAHO S, VANNINEN R, PURANEN M et al. Risk of harboring an unruptured intracranial aneurysm. Stroke 1998; 29: 359-362.
52. RUIZ-SANDOVAL JL, CANTU C, BARINAGARREMENTERIA F. Intracerebral hemorrhage in young people: analysis of risk factors, location, causes, and prognosis. Stroke 1999; 30: 537-541.
53. SCHIEVINK WI, KAREMAKER JM, HAGEMAN LM, VAN DER WERF DJ. Circumstances surrounding aneurysmal subarachnoid hemorrhage. Surg Neurol 1989; 32: 266-272.
54. SCHIEVINK WI, WIJDICKS EF, PARISI JE, PIEPGRAS DG, WHISNANT JP. Sudden death from aneurysmal subarachnoid hemorrhage. Neurology 1995; 45: 871-874.
55. SCHIEVINK WI. Intracranial aneurysms. N Engl J Med 1997; 336: 28-40.
56. STEWART JA, DUNDAS R, HOWARD RS, RUDD AG, WOLFE CD. Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ 1999; 318(7189): 967-971.
57. The arteriovenous malfomration study group. Arteriovenous malformations of the brain in adults. N Engl J Med 1999; 340: 1812-1818.
58. THRIFT AG, McNEIL JJ, FORBES A, DONNAN GA. Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study. BMJ 1999; 318: 759-764.
59. THRIFT AG, McNEIL JJ, FORBES A, DONNAN GA. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 1998; 31: 1223-1229.
60. TSEMENTZIS SA, KENNET RP, HITCHCOCK ER, GILL JS, BEEVERS DG. Seasonal variation of cerebrovascular diseases. Acta Neurochir (Wien) 1991; 111: 80-83.
61. TUHRIM S, HOROWITZ DR, SACHER M, GODBOLD JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med 1995; 23: 950-954.
62. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group. Br Med J (Clin Res Ed) 1988; 296: 316-320.
63. VESSEY MP, VILLARD-MACKINTOSH L, MCPHERSON K, YEATES D. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. BMJ 1989; 299: 1487-1491.
64. WINN HR, JANE JA SR, TAYLOR J, KAISER D, BRITZ GW. Prevalence of asymptomatic incidental aneurysms: review of 4568 arteriograms. J Neurosurg 2002; 96: 43-49.
65. WOO D, SAUERBECK LR, KISSELA BM, KHOURY JC, SZAFLARSKI JP, GEBEL J et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002; 33: 1190-1196.